With the analysis among 4,140 patents, we discovered top 450 key players by total patent application. Amgen, Inc., Rinat Neuroscience Corp., Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 9.35% of the total patent filing.
California, United States
Patent: 154
California, United States
Patent: 123
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 110
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 84
Connecticut, United States
Patent: 69
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 68
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 55
New York, United States
Patent: 48
California, United States
Patent: 45
With the analysis among 56 patents, we discovered top 8 start-ups by total patent application. SyntheX, Inc., Hoba Therapeutics ApS, Institut National de la Santé et de la Recherche Médicale are active in this area.
California, United States
Patent: 32
Hovedstaden, Denmark
Patent: 11
Institut National de la Santé et de la Recherche Médicale
Gyeonggi-do, South Korea
Patent: 3
Pennsylvania, United States
Patent: 2
Intarcia Therapeutics, Inc.
California, United States
Patent: 1
Texas, United States
Patent: 1
With the analysis among related 361 patents applied in the last 5 years. We discover 170 most active companies in this area. The fast-growing Pfizer Inc., Akeso Biopharma Co., Ltd., Jiangsu Zhongxin Pharmaceutical Co., Ltd. take 11.91% of patent filing during this period.
New York, United States
Patent: 16
Akeso Biopharma Co., Ltd.
Guangdong Sheng, China
Patent: 15
Jiangsu Zhongxin Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 10
Paradigm Biopharmaceuticals Ltd.
Victoria, Australia
Patent: 9
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 9
Trinomab Biotech Co., Ltd
Guangdong Sheng, China
Patent: 7
New Hampshire, United States
Patent: 7
undefined undefined
Patent: 7
Shanghai Cp Guojian Pharmaceutical Co Ltd.
Shanghai Shi, China
Patent: 7
With the analysis among related 361 patents in last 5 years, we discover 108 new entrants. Akeso Biopharma Co., Ltd., Jiangsu Zhongxin Pharmaceutical Co., Ltd., Paradigm Biopharmaceuticals Ltd. are the most active new entrants in this area.
Akeso Biopharma Co., Ltd.
Guangdong Sheng, China
Patent: 15
Jiangsu Zhongxin Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Paradigm Biopharmaceuticals Ltd.
Victoria, Australia
Patent: 9
Trinomab Biotech Co., Ltd
Guangdong Sheng, China
Patent: 7
undefined undefined
Patent: 7
Shanghai Cp Guojian Pharmaceutical Co Ltd.
Shanghai Shi, China
Patent: 7
Alma Mater Studiorum - Università di Bologna
Emilia-Romagna, Italy
Patent: 4
Suzhou Hybiome Biomedical Engineering Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Università degli Studi dell'Aquila
Tashi Pharmaceutical (Guangdong) Co Ltd
Guangdong Sheng, China
Patent: 3
With the analysis among 1,201 patents, we discovered top 194 universities and scientific research institutions by total patent application. Washington University in St. Louis, University of South Florida, President & Fellows of Harvard College are dominant in this area. They take 12.16% of the total patent filing.
Washington University in St. Louis
Missouri, United States
Patent: 41
University of South Florida
President & Fellows of Harvard College
Massachusetts, United States
Patent: 32
Minnesota, United States
Patent: 26
Zhejiang Sheng, China
Patent: 25
ZURICH, Switzerland
Patent: 24
Connecticut, United States
Patent: 20
New York, United States
Patent: 17
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 15
The Johns Hopkins University